Similar articles

• Predictability of response to endocrine ablation in breast cancer.

  Criss WE, Bland KI, O'Leary JP. Criss WE, et al. South Med J. 1975 Jun;68(6):714-6. doi: 10.1097/00007611-197506000-00013. South Med J. 1975. PMID: 166448
• Prolactin and breast carcinoma.

  Smithline F, Sherman L, Kolodny D. Smithline F, et al. N Engl J Med. 1975 Apr 10;292(15):784-92. doi: 10.1056/NEJM197504102921506. N Engl J Med. 1975. PMID: 1089886 Review.
• Interrelationship between pituitary and ovarian hormones in normal and neoplastic growth of mammary glands of mice.

  Nagasawa H, Ohta K, Nakajima K, Noguchi Y, Miura K, Niki K, Namiki H. Nagasawa H, et al. Ann N Y Acad Sci. 1986;464:301-15. doi: 10.1111/j.1749-6632.1986.tb16011.x. Ann N Y Acad Sci. 1986. PMID: 2942074
• Prolactin and estrogen receptors in breast cancer.

  McGuire WL, Chamness GC, Horwitz KB, Zava DT. McGuire WL, et al. Pathobiol Annu. 1977;7:191-211. Pathobiol Annu. 1977. PMID: 201904 Review. No abstract available.
• Hormone-dependence of experimental mammary tumours.

  Escrich E. Escrich E. Rev Esp Fisiol. 1990 Mar;46(1):89-94. Rev Esp Fisiol. 1990. PMID: 2168573 Review.